pared with men of a similar age. ApEn showed an age-related increase in both sexes and was higher in premenopausal and postmenopausal women than in men of comparable age (p < 0.0001). A single fasting GH measurement is not informative of 24-hour GH secretion. Conclusions: BMI dominates the negative regulation of 24-hour GH secretion across 5 decades of age in this up till now largest cohort of healthy adults who underwent 24-hour blood sampling. Sex also impacts GH secretion before the age of 50 years as well as its regularity at all ages. Differences in serum IGF-1 partly depend on the pre-or postmenopausal state. Finally, a single GH measurement is not informative of 24-hour GH secretion.
ative feedback signals by short-loop actions of GH and insulin-like growth factor (IGF)-1 [1] . Temporary interactions between these signals lead to both basal (nonpulsatile) and pulsatile (burst-like) GH secretion. GH secretion is further modified by age, sex, the sleep-wake cycle, sex hormones, feeding, stress, adiposity, acute and chronic illness, including kidney and liver failure, and medication. Most of the present knowledge about GH secretion is based on single GH measurements or acute testing with stimulatory factors, including GHRH and GHRPs [1] . Single GH measurements and stimulated GH concentrations or urinary GH excretion do not generally reflect GH secretion. The only way to quantitate the latter is by frequent measurements of GH concentrations during 24 h. Such studies have been performed in selected groups of healthy individuals and in patients with various endocrine disorders including acromegaly, GH deficiency, and Cushing's disease, as well as in patients with neurological disorders such as narcolepsy, Parkinson's disease and Huntington's disease, but rarely in large cohorts of disease-and medication-free volunteers over several decades of age with a wide body mass index (BMI) spectrum.
In previous studies, the age and BMI ranges of the volunteers were generally narrow, and mostly only one gender was included. Analyses of such restricted data sets may lead to statistical type I or type II errors. Given the correlations between age, BMI, and gender, multivariate regression is needed for definitive inferences. Nonetheless, multivariate analysis is unreliable in small cohorts. Overcoming these obstacles would require the investigation of a larger cohort of healthy adults, both men and women, over wider ranges of age and BMI. To this end, the present study, which is an extension of a previous report, retrospectively examines the dependency of GH secretion dynamics [basal, pulsatile, and total 24-hour secretion and approximate entropy (ApEn)] on individual and/or combined clinical characteristics in 130 healthy individuals sampled frequently (every 10 min) for a sufficiently representative duration (24 h ) and analyzed with a high-sensitivity GH assay (immunofluorometric platform).
Methods

Clinical Protocol
The cohort of healthy Caucasian individuals studied in this project originated from different studies, in which they served as controls, including studies on GH secretion in patients with acromegaly, sex differences in GH secretion, obese subjects, patients with polycystic ovary syndrome, and patients with neurological disorders [2] [3] [4] [5] [6] [7] [8] [9] [10] . In these studies, healthy women and men also volunteered for and completed the sampling study. The subjects originated from the western provinces of the Netherlands and were recruited by advertisements in local newspapers. They were evaluated in an identical sampling paradigm and with the same GH and IGF-1 assays (see below). The clinical characteristics of the subjects (85 women and 45 men) are listed in table 1 .
The postmenopausal women studied here did not use estrogen therapy. Premenopausal women were required to have regular menstrual cycles and not to use oral contraceptives, and they were studied in the follicular phase of the menstrual cycle. The participants maintained conventional work and sleeping patterns and reported no recent (within 10 days) transmeridian travel, weight change (>2 kg in 6 weeks), pregnancy (women), shift work, psychosocial stress, prescription medical use, substance abuse, neuropsychiatric illness, or acute or chronic systemic disease. Their complete medical history, physical examination, and screening biochemistry test results, including free thyroxine levels, were normal. Volunteers were admitted to the study unit the evening before sampling. Ambulation was permitted to the lavatory only. Vigorous exercise, snacks, caffeinated beverages, and cigarette smoking were disallowed. Meals were provided at 09.00, 12.30, and 17.30 h, and room lights were turned off between 22.00 and 24.00 h, depending on the individual sleeping habits. Blood samples (2 ml) were drawn at 10-min intervals for 24 h.
The volunteers were compensated for the time spent in the study. All analyses reported here used techniques not previously applied in any of the published studies. Informed written consent was obtained and approved by the Ethics Committee of the Leiden University Medical Center. 337 grams per liter, divide by 2.6). The limit of detection (defined as the value 2 SD above the mean value of the zero standard) was 0.03 mU/l (0.0115 μg/l). The intra-assay coefficient of variation (CV) varied from 1.6 to 8.4% in the assay range of 0.26-47 mU/l, with a corresponding interassay CV of 2.0-9.9%.
Assays
The total serum IGF-1 concentration was measured by RIA (Incstar, Stillwater, Minn., USA). The preceding purification and extraction steps were as follows: 0.25 ml of serum was acidified with 1.0 ml of 0.5 mol HCl and pushed slowly (3 min) through an octadecylsilyl silica cartridge attached to a 10-ml syringe; after washing with 20 ml acetic acid (4%), the IGF-1 fraction was eluted (3 min) with 4 ml highly purified methanol and evaporated in air. The mean IG recovery was 96% (range 90-110), the detection limit 1.5 nmol/l, and the interassay CV was <11%. All IGF-1 measurements were performed by the same technician [11] .
Deconvolution Analysis GH concentration time series were analyzed with a recently developed automated deconvolution method empirically validated using hypothalamic-pituitary sampling and simulated pulsatile time series [12] [13] [14] . The Matlab-based algorithm first detrends the data and normalizes concentrations to the unit interval [0 1]. Second, the program creates multiple successive potential pulse time sets, each containing one fewer burst via a smoothing process (a nonlinear adaptation of the heat diffusion equation). Third, a maximum likelihood expectation estimation method computes all secretion and elimination parameters simultaneously, conditional on each of the multiple candidate pulse time sets.
Deconvolution parameters comprise basal secretion, two halflives, secretory burst mass, random effects on burst mass, measurement error, and a three-parameter flexible gamma secretory-burst waveform. The fast half-life was fixed to 3.5 min and the slow halflife was estimated as an unknown variable between 8 and 22 min. The fast half-life constituted 37% of the decay amplitude. All candidate pulse time sets were deconvolved. Statistical model selection was then performed to distinguish between the independently framed fits of the multiple candidate pulse time sets using the Akaike information criterion. The parameters (and units) are frequency (number of bursts per 24 h), slow half-life (min), mass secreted per burst (concentration units), basal and pulsatile secretion rates (concentration units), and waveform shape (mode, or time delay to maximal secretion after burst onset, in min).
Approximate Entropy
ApEn was used as a scale-and model-independent regularity statistic to quantify the orderliness or regularity of consecutive serum GH concentration measurements over 24 h. Normalized ApEn parameters of m = 1 (test range) and r = 20% (threshold) of the intraseries SD were used. The ApEn metric evaluates the consistency of recurrent subordinate (nonpulsatile) patterns in the data, and thus yields information distinct from and complementary to deconvolution (pulse) analyses [15] [16] [17] .
Statistical Analyses
The influence of variables on GH secretion was explored with regression techniques. Multivariate linear regression analyses of untransformed GH measures were used to examine correlations between preselected GH parameters (dependent variables) and one or more of age, BMI, gender, and IGF-1 (independent variables). Statistical comparisons by gender were carried out by the unpaired two-tailed Student t test. Data are given as medians and ranges, or as means and SD, as specified. Analyses were done with Systat version 13.1 (Systat Software GmbH, Erkrath, Germany).
Figures were constructed in SigmaPlot 13 (Systat). p < 0.05 was considered significant.
Results
The median age of the subjects was 40 years (range 20-77). The median BMI was 26 (range 18.3-49.8). In table 1 , age, BMI, and hormone measurements are shown stratified according to sex. The median age was lower in women than in men, while the BMI and mean serum GH concentration were higher.
Total 24-hour GH secretion was negatively correlated with age and BMI (R 2 = 0.21, p < 0.0001; age β coefficient -3.35 ± 1.12, p = 0.003; BMI β coefficient -12.5 ± 2.23, p < 0.0001). The impact of BMI was 3.5-fold larger than that of age ( fig. 1 ). As shown in figure 2 , pulsatile GH secretion was influenced in a comparable way by age and BMI (R 2 = 0.23, p < 0.001; age β coefficient -3.16 ± 0.98, p = 0.002; BMI β coefficient -11.25 ± 1.94, p < 0.0001; fig. 2 ). Basal (nonpulsatile) GH secretion was only weak- The impact of sex on GH secretion also depended on age. Women younger than 50 years had a 2-fold higher basal, pulsatile, and total GH secretion compared with men in the same age range, but the sex differences for pulsatile and total GH secretion were no longer significant in subjects older than 50 years ( table 2 ) .
Multivariate regression was also applied to assess the association of total IGF-1 (dependent variable) with age, BMI, and logarithmically transformed basal, pulsatile, and total GH secretion (independent variables). In this ( fig. 4 ) .
The total IGF-1 of the whole group showed no sex differences, as shown in table 1 (p = 0.41). However, beyond the age of 50 years, women had a lower IGF-1 concentration than men, as shown in table 3 (p = 0.006). In subjects younger than 50 years, no sex differences for total IGF-1 were present (p = 0.44). The same table also shows the sex hormone levels according to age and sex. The postmenopausal women had lower estradiol levels than the younger women, although the majority was sampled early in the follicular phase. In men there was no decrease in serum testosterone concentration beyond the age of 50 years.
GH ApEn, a measure of secretion irregularity and network complexity, was positively associated with age. In Blue symbols reflect the data points above the regression plane, while the green circles represent those under the regression surface. Data are show as medians (ranges). Statistical comparisons were made with the two-tailed Student test after logarithmically transforming the data. IGF-1 comparisons were made between the sexes for subjects younger and older than 50 years. Serum sex hormone concentrations were compared between subjects younger and older than 50 years. figures 5 and 6 , the relation between age, BMI, and ApEn is shown for men and women. Increasing age causes a modest increase in GH ApEn. BMI in women tended to increase ApEn, but this effect failed to reach statistical significance. GH ApEn was higher in women than in men, irrespective of age (p < 0.0001; table 2 ).
As a proxy for feedback of serum IGF-1 on GH secretion versus age, we used the natural logarithm of the ratio of pulsatile (basal) GH secretion and IGF-1 concentration and regressed the ratio versus age in women and men. No significant relation was found in both sexes, suggesting that feedback was not age dependent.
The relation between the logarithmically (base 10) transformed fasting serum GH concentration and 24-hour secretion rate is plotted in figure 7 . The linear regression of the transformed data was highly significant (p < 0.0001, R 2 = 0.21). Nonetheless, for a given GH concentration, the GH secretion rate differed about 10-fold. The correlation between the untransformed fasting serum GH concentration and 24-hour GH secretion was R 2 = 0.05 (p = 0.009), explaining only 5% of the variability.
Discussion
The main findings of this study are as follows: (1) total and pulsatile 24-hour GH secretion is negatively associated with age and BMI; (2) the influence of sex is age dependent, as below 50 years, GH secretion is higher in women than in men, but no longer beyond 50 years; (3) IGF-1 levels are negatively determined by age; (4) GH ApEn is positively associated with age, and higher in women than in men, irrespective of age, and (5) a single fasting GH measurement is a poor predictor of 24-hour GH secretion, and the variation in the latter is about 10-fold.
The study is an extension of a previous report in which we analyzed determinants of GH secretion in 100 healthy volunteers [18] . The present results pertain to 130 healthy volunteers investigated with a similar clinical protocol, as well as the same hormone measurements and mathematical tools for data analyses, but with novel findings. In the present investigation, age and BMI were independent predictors of pulsatile GH secretion, while in the previous report these two factors could not be dissociated. Interestingly, the negative impact of BMI on GH secretion was almost 3.5-fold larger than age per se, which has not been reported till now.
Human studies investigating the influence of age are generally limited to contrasting relatively young subjects with older subjects [19, 20] , while studies spanning 5 decades are rare [18, 21, 22] . The study of Zadik et al. [21] , who measured integrated 24-hour GH levels in 138 healthy volunteers, established an exponential decline across the decades, resulting in an about 80% decrease in GH secretion at 65 years of age, but with large individual differences within age bins of 10 years. Comparable agerelated decreases in GH secretion are found in laboratory animals [23] [24] [25] . The GH decrease observed in aging is mediated primarily by a diminishment of pulse amplitude, suggesting a reduced net GHRH drive [26] . In aged rats, hypothalamic mRNA and immunoreactive GHRH are decreased [27] and accompanied by a decreased number of somatotrophs and a diminished pituitary GH content [28, 29] . Nevertheless, administration of GHRH can (partially) restore GH levels in aged humans and animals, which can be further amplified by concomitant use of GH-releasing peptides such as ghrelin, GHRP-2, and GHRP-6 [27, [30] [31] [32] .
Obesity is a very strong inhibitor of spontaneous GH secretion and the response to secretagogues [33, 34] . In this retrospective study, we could use BMI only as a proxy for adiposity, because of its availability in all subjects. Increased abdominal visceral fat mass is the best predictor of GH secretion attenuation in humans, and dietary restriction leading to substantial weight loss restored GH impairment in some but not all studies. Discrepancies between studies may relate to the degree of reduction of fat storage size [35] [36] [37] [38] . A comparable observation is available for laboratory animals, in which GH secretion decreases substantially during overfeeding [23, 39] . The (patho)physiological pathways involved in GH suppression in obesity are not established, and experimental data on central effects via hypothalamic GHRH, ghrelin, and somatostatin are conflicting [40] [41] [42] . Several feedback mechanisms have been proposed, including insulin, free IGF-1, and free fatty acids (FFAs). Acute elevation of FFA in normal subjects diminishes GH secretion [43, 44] , while lowering of FFA with acipimox in obese subjects increases spontaneous GH secretion, possibly by a direct effect on the somatotroph [9, 45] .
Insulin has been implicated in feedback of GH, and the first description of its direct effect on rat pituitary GH mRNA was published almost 3 decades ago, and more recently for mice [46, 47] . Indirect supporting evidence for the role of insulin in GH feedback in humans has been observed in several clinical studies in obesity [33, 48, 49] .
Publications on the influence of BMI on serum levels of IGF-1 are not unanimous. One Dutch study found a borderline significant negative effect of BMI in a cohort of 296 healthy volunteers, with age and BMI ranges comparable to those in our study [50] . Another cross-sectional study in 351 subjects described a significant negative effect of BMI, which was no longer present in the multivariate regression together with age [51] . Finally, in a community-based cohort of 432 elderly subjects with a mean age of about 60 years, neither BMI nor visceral adipose tissue correlated with IGF-1 [52] . These different outcomes are not readily explainable, but it would appear that age is an important interacting factor, which should be taken into account. However, there is no doubt that an extremely low or high BMI impacts negatively on serum IGF-1 [53] .
Whereas under physiological conditions IGF-1 is synthesized and secreted by the liver after binding of GH to the GH receptor and activation of the specific pathway, under conditions of GH deficiency high insulin levels can (partly) compensate IGF-1 secretion in the liver. Whether this is also true for locally produced IGF-1 in peripheral organs is not known. In addition, insulin also leads to decreased IGFBP-1 levels, which together with amplified IGF-1 levels cause an increase in free IGF-1 and thus enhance the negative feedback on GH release [54] . The magnitude of this mechanism, which has been demonstrated directly in rats, can only be assessed in men by blocking the IGF-1 receptor with specific drugs -if they are safe for use in clinical endocrine research [55] . In the present investigation, we did not find support for an increased feedback of total IGF-1 on GH secretion. This does not necessarily exclude a possible role for free IGF-1.
ApEn was positively related to age for both genders. ApEn, a surrogate measure of reduced feedback integration, is increased for instance for TSH in primary hypothyroidism [56] . For GH, feedback has not been fully studied, although IGF-1 infusions do reduce GH ApEn in men and women [57] [58] [59] . The impact of aging on the regularity of hormone secretion by the various pituitary systems is not uniform. For instance, ACTH secretion patterns are sex and age independent, while cortisol ApEn increases during aging only in men [60] . On the other hand, TSH secretory regularity is sex and age independent, whereas PRL ApEn is higher in men older than 50 years, compared with younger subjects, but not in women [61, 62] . Finally, LH ApEn in elderly men (60-70 years) is higher than in younger men (20-34 years) , and comparable results have been found in postmenopausal versus premenopausal women [63, 64] .
Not unexpectedly, but never investigated before, the predictive power of a single GH measurement for 24-hour GH secretion estimation, even in a large group of adults, is very poor, explaining only 5% of the variability. This result contrasts with a single TSH measurement, which explains two thirds of the variance of 24-hour TSH secretion [62] .
The influence of age on GH and IGF-1 was gender dependent. Previously, we found a greater GH secretion in premenopausal women than in men of similar age [5] . Here, we confirm this finding, but also that the difference is no longer present after the age of 50 years. In our series, this cutoff is representative of the premenopausal versus postmenopausal state. This result agrees with earlier data on men and women older and younger than 50 years, in whom the sex differences in integrated 24-hour GH levels were no longer present in the cohorts older than 50 years [20] . Transdermal estradiol amplifies GH secretion, both under basal conditions and during submaximal infusions of GHRH and GHRP-2 in leuprolide-clamped premenopausal and postmenopausal women, but less so in older women [65, 66] , indicating that age is an important physiological variable. The mechanisms of the GH-promoting effect of estradiol are still not fully elucidated. Possible effects of estradiol are its potentiating impact on GHRH and/or ghrelin. The latter possibility of an increased sensitivity of the somatotrope was found in postmenopausal women in a dose-response experiment [67] . Experiments in male and female rats have shown that blocking the estradiol receptor with tamoxifen decreased spontaneous 6-hour GH secretion. The decrease could be restored by anti-somatostatin serum, suggesting that part of the estradiol effect is somatostatin mediated [68] . Finally, another contributing GH-stimulatory effect of estrogens is disinhibition of the negative feedback of IGF-1 on pulsatile GH secretion [59] . The relative contribution of each of these possible mechanisms is presently unknown.
Interestingly, IGF-1 levels were similar by sex in subjects younger than 50 years, but beyond this age, women have lower serum IGF-1 levels. In a recent, large study of IGF-1 levels in healthy individuals measured with a new, precise, automated chemiluminescence immunoassay, the authors found slightly lower IGF-1 levels in adult women across all decades [53] . In a systematic review on long-term effects of recombinant human GH replacement, the GH dose given to women older than 50 years without estradiol replacement was similar to that for men of comparable age. Nonetheless, while the women reached a mean zero SD score for IGF-1, the men had scores between 1.0 and 2.0 [69] . Although the IGF-1 levels in our series were similar in men and women younger than 50 years, women in this age category were heavier (mean difference in BMI = 4.6), which may have contributed to a relative increase in IGF-1. Globally, this finding suggests that the diminished hepatic IGF-1 sensitivity to GH in women persists after menopause. However, this postulate should be tested by appropriate dose-response analyses.
A limitation of our study is its retrospective character, so that, for instance, we had no data on visceral fat mass, except for a limited number of subjects. On the other hand, measures such as BMI or waist circumference are readily available and can be used in clinical practice. It was essential for this work that the sampling scheme and laboratory methods were unchanged during the period of data collection.
In summary, this study shows a striking negative impact of BMI on spontaneous GH secretion along with increasing age. In addition, the influence of gender on GH secretion, its regularity, and IGF-1 is (partly) related to the pre-versus postmenopausal state. Finally, a single fasting GH measurement is not informative of GH secretion and must be discouraged. Clinical studies on GH secretion should take in account all major determinants of GH secretion.
